Sophia Antipolis, France

Press Release – For immediate release – 5:45p CEST

Median Technologies launches ImageBank™ – New service offering enables efficient medical image collection and storage for Phase I oncology clinical trials.

Median Technologies, the industry-leading Imaging Phenomics Company® (Paris:ALMDT), announced today the launch of ImageBank™. This service offering extends Median’s imaging contract research organization (iCRO) business with enhanced medical image collection and storage capabilities for cancer centers involved in Phase I oncology studies. Median’s ImageBank enables sponsors to efficiently collect and hold medical images – making those images available for potential radiological assessments during or after the conclusion of clinical research.

“Phase I cancer centers often are asked to provide medical images after trials start to further evaluate cancer evolution in patients. It can be difficult to access images retrospectively, or during the trials, if the appropriate retrieval infrastructure hasn’t been implemented from the start”, said Nicholas Campbell, Chief Commercial Officer at Median Technologies. “We have designed ImageBank to fill this gap with a proactive, cost-effective solution for potential image review during or after Phase I studies. ImageBank helps cancer centers anticipate sponsor requests for image reads. From a sponsor perspective, image analysis in Phase I studies is an important tool to make a first assessment of the drug efficacy and enable faster go, no-go decisions”, Campbell added.

Using ImageBank, medical images are transferred electronically in real-time from cancer centers to a secured database where images are stored and ready for analysis at any time. Based on Median’s experienced network of radiologists, on-demand reads using appropriate assessment criteria can be provided. ImageBank solution is available for Phase I worldwide.

Download 20180426_ImageBank_PR_final.pdf